2m 2m 2m 2m 2m 2m 2m
RIGEL PHARM (RIGL)
NASDAQ
$45.84-$1.13 (-2.41%)
Price as of Oct 02, 2026 5:07 PM EDT- $877.4MMarket Cap
- 67.03%1-Year Change
- BiotechnologyIndustry
RIGEL PHARM (RIGL)
$45.84-$1.13 (-2.41%)
RIGL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $46.97 | ||
Change | -$1.18 (-2.45%) | ||
Open | $48.05 | ||
High | $48.87 | ||
Low | $46.81 | ||
Previous Close | $48.15 | ||
Volume | 234,998 | ||
30-Day Average Volume | 232,807 | ||
1-Week Change | -1.92% | ||
1-Month Change | -1.12% | ||
1-Year Change | 67.03% | ||
3-Year Change | 334.91% | ||
5-Year Change | 33.06% | ||
Fundamentals | |||
Shares Outstanding | 18.7M | ||
Total Assets | $521.1M | ||
Market Cap | $877.4M | ||
Enterprise Value | $855.8M | ||
Period: QTR TTM FY | |||
Revenue | $67.0M | ||
Net Income | $17.3M | ||
Free Cash Flow | $30.7M | ||
EBIT | $24.4M | ||
EBITDA | $25.2M | ||
Net Working Capital | $89.9M | ||
EPS | $0.88 | ||
Enterprise Value/EBITDA | 34 | ||
Enterprise Value/Revenue | 13 | ||
P/B | 2 | ||
P/E | 53 | ||
PEG | 1 | ||
Price/Free Cash Flow | 29 | ||
Price/Operating Cash Flow | 29 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 06/27/2024 | ||
Earnings & Revenue